Inverse planned constant dose rate volumetric modulated arc therapy (VMAT) as an efficient alternative to five-field intensity modulated radiation therapy (IMRT) for prostate

Journal of Radiotherapy in Practice

Volumn 13, Issue 1, 2014, Pages 68-78

  McGarry, Conor K ^a,b   McMahon, Stephen J ^b   Craft, David ^c   O'Sullivan, Joe M ^a,b   Prise, Kevin M ^b   Hounsell, Alan R ^a,b  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

constant dose rate VMAT; IMRT; Pareto; prostate

Indexed keywords

ARTICLE; CANCER CONTROL; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; CONSTANT DOSE RATE; DOSIMETRY; GAMMA IRRADIATION; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LINEAR ACCELERATOR; LOW ENERGY RADIATION; MALE; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION RESPONSE; RADIOTHERAPY; RADIOTHERAPY PLANNING SYSTEM; TREATMENT PLANNING; VOLUMETRIC MODULATED ARC THERAPY; ACCURACY; CONTRAST RADIOGRAPHY; CONTROL SYSTEM; CONTROLLED STUDY; INTERMETHOD COMPARISON; OUTCOME ASSESSMENT;

EID: 84896454520     PISSN: 14603969     EISSN: 14671131     Source Type: Journal    
DOI: 10.1017/S1460396913000083     Document Type: Article

References (35)

1. Veldeman L, Madani I, Hulstaert F, De Meerleer G, Mareel M, De Neve W. Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies. Lancet Oncol 2008; 9 (4): 367-375.
2. Kuperman V Y, Ventura A M, Sommerfeldt M. Effect of radiation protraction in intensity-modulated radiation therapy with direct aperture optimization: a phantom study. Phys Med Biol 2008; 53 (12): 3279-3292.
3. Bewes J M, Suchowerska N, Jackson M, Zhang M, McKenzie D R. The radiobiological effect of intra-fraction dose-rate modulation in intensity modulated radiation therapy (IMRT). Phys Med Biol 2008; 53 (13): 3567-3578.
4. Zhang P, Happersett L, Hunt M, Jackson A, Zelefsky M, Mageras G. Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases. Int J Radiat Oncol Biol Phys 2010; 76 (5): 1456-1462.
5. Dobler B, Weidner K, Koelbl O. Application of volumetric modulated arc therapy (VMAT) in a dual-vendor environment. Radiat Oncol 2010; 5 (1): 95.
6. Bedford J L. Treatment planning for volumetric modulated arc therapy. Med Phys 2009; 36 (11): 5128-5138.
7. Verbakel W F, Cuijpers J P, Hoffmans D, Bieker M, Slotman B J, Senan S. Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-And-neck cancer: a comparative planning and dosimetric study. Int J Radiat Oncol Biol Phys 2009; 74 (1): 252-259.
8. Bzdusek K, Friberger H, Eriksson K, Ha°rdemark B, Robinson D, Kaus M. Development and evaluation of an efficient approach to volumetric arc therapy planning. Med Phys 2009; 36 (6): 2328-2339.
9. Otto K. Volumetric modulated arc therapy: IMRT in a single gantry arc. Med Phys 2008; 35 (1): 310-317.
10. Yu C X, Tang G. Intensity-modulated arc therapy: principles, technologies and clinical implementation. Phys Med Biol 2011; 56 (5): R31-R54.
11. Tang G, Earl M A, Yu C X. Variable dose rate single-Arc IMAT delivered with a constant dose rate and variable angular spacing. Phys Med Biol 2009; 54 (21): 6439-6456.
12. Palma D, Vollans E, James K et al. Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2008; 72 (4): 996-1001.
13. Feygelman V, Zhang G, Stevens C. Initial dosimetric evaluation of SmartArc-A novel VMAT treatment planning module implemented in a multi-vendor delivery chain. J Appl Clin Med Phys 2010; 11 (1): 3169.
14. Ezzell G A, Burmeister J W, Dogan N et al. IMRT commissioning: multiple institution planning and dosime-try comparisons, a report from AAPM Task Group 119. Med Phys 2009; 36 (11): 5359-5373.
15. Vanetti E, Nicolini G, Clivio A, Fogliata A, Cozzi L. The impact of treatment couch modelling on RapidArc. Phys Med Biol 2009; 54 (9): N157-N166.
16. Li H, Lee A K, Johnson J L, Zhu R X, Kudchadker R J. Characterization of dose impact on IMRT and VMAT from couch attenuation for two Varian couches. J Appl Clin Med Phys 2011; 12 (3): 3471.
17. Seppälä J K, Kulmala J A. Increased beam attenuation and surface dose by different couch inserts of treatment tables used in megavoltage radiotherapy. J Appl Clin Med Phys 2011; 12 (4): 3554.
18. Smith D W, Christophides D, Dean C, Naisbit M, Mason J, Morgan A. Dosimetric characterization of the iBEAM evo carbon fiber couch for radiotherapy. Med Phys 2010; 37 (7): 3595-3606.
19. Pulliam K B, Howell R M, Followill D, Luo D, White R A, Kry S F. The clinical impact of the couch top and rails on IMRT and arc therapy. Phys Med Biol 2011; 56 (23): 7435-7447.
20. McGarry C K, O'Sullivan J M, Hounsell A R. Impact of modeling the treatment couch for VMAT treatments. Med Phys 2010; 37 (6): 3239.
21. Ottosson R O, Engstrom P E, Sjöström D et al. The feasibility of using Pareto fronts for comparison of treatment planning systems and delivery techniques. Acta Oncol 2009; 48 (2): 233-237.
22. Petersson K, Ceberg C, Engström P, Benedek H, Nilsson P, Knöös T. Conversion of helical tomotherapy plans to step-And-shoot IMRT plans-Pareto front evaluation of plans from a new treatment planning system. Med Phys 2011; 38 (6): 3130-3138.
23. Craft D, Halabi T, Bortfeld T. Exploration of tradeoffs in intensity-modulated radiotherapy. Phys Med Biol 2005; 50 (24): 5857-5868.
24. Khoo V S, Dearnaley D P. Question of dose, fractionation and technique: ingredients for testing hypofractionation in prostate cancer-The CHHiP trial. Clin Oncol (R Coll Radiol) 2008; 20 (1): 12-14.
25. Mott J H, Livsey J E, Logue J P. Development of a simultaneous boost IMRT class solution for a hypofractionated prostate cancer protocol. Br J Radiol 2004; 77 (917): 377-386.
26. Boylan C J, Golby C, Rowbottom C G. A VMAT planning solution for prostate patients using a commercial treatment planning system. Phys Med Biol 2010; 55 (14): N395-N404.
27. Grégoire V, Mackie T R. State of the art on dose prescription, reporting and recording in Intensity-Modulated Radiation Therapy (ICRU report No. 83). Cancer Radio-Ther 2011; 15 (6-7): 555-559.
28. Webb S, Nahum A E. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. Phys Med Biol 1993; 38 (6): 653-666.
29. Wang J Z, Guerrero M, Li X A. How low is the alpha/beta ratio for prostate cancer? Int J Radiat Oncol Biol Phys 2003; 55 (1): 194-203.
30. Kutcher G J, Burman C, Brewster L, Goitein M, Mohan R. Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations. Int J Radiat Oncol Biol Phys 1991; 21 (1): 137-146.
31. Burman C, Kutcher G J, Emami B, Goitein M. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 1991; 21 (1): 123-135.
32. Alvarez-Moret J, Pohl F, Koelbl O, Dobler B. Evaluation of volumetric modulated arc therapy (VMAT) with Oncentra MasterPlan for the treatment of head and neck cancer. Radiat Oncol 2010; 5: 110.
33. Craft D, McQuaid D, Wala J, Chen W, Salari E, Bortfeld T. Multicriteria VMAT optimization. Med Phys 2012; 39 (2): 686-696.
34. McGarry C K, Chinneck C D, O'Toole M M, O'Sullivan J M, Prise K M, Hounsell A R. Assessing software upgrades, plan properties and patient geometry using intensity modulated radiation therapy (IMRT) complexity metrics. Med Phys 2011; 38 (4): 2027-2034.
35. Lang S, Reggiori G, Puxeu Vaque J et al. Pretreatment quality assurance of flattening filter free beams on 224 patients for intensity modulated plans: a multicentric study. Med Phys 2012; 39 (3): 1351-1356.